Four Systemic Lupus Erythematosus Subgroups, Defined by Autoantibodies Status, Differ Regarding HLA‐DRB1 Genotype Associations and Immunological and Clinical Manifestations

OBJECTIVE: The heterogeneity of systemic lupus erythematosus (SLE) constitutes clinical and therapeutical challenges. We therefore studied whether unrecognized disease subgroups can be identified by using autoantibody profiling together with HLA‐DRB1 alleles and immunological and clinical data. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Diaz‐Gallo, Lina‐Marcela, Oke, Vilija, Lundström, Emeli, Elvin, Kerstin, Ling Wu, Yee, Eketjäll, Susanna, Zickert, Agneta, Gustafsson, Johanna T., Jönsen, Andreas, Leonard, Dag, Birmingham, Daniel J., Nordmark, Gunnel, Bengtsson, Anders A., Rönnblom, Lars, Gunnarsson, Iva, Yu, Chack‐Yung, Padyukov, Leonid, Svenungsson, Elisabet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754019/
https://www.ncbi.nlm.nih.gov/pubmed/34658170
http://dx.doi.org/10.1002/acr2.11343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754019/
https://www.ncbi.nlm.nih.gov/pubmed/34658170
http://dx.doi.org/10.1002/acr2.11343

Ejemplares similares